SCHEMBL5478792

SCHEMBL5478792

CCOCCOCCOCCO[C]=O

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
TSHR P16473 1/20 0.41
THRB P10828 1/20 0.35
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5393746 1.00 ALDH1A1 (0.41) ALDH1A1TSHRTHRBGAA
SCHEMBL225859 0.97
SCHEMBL9181433 0.93 TSHR (0.37) ALDH1A1TSHRTHRBGAA
SCHEMBL9179902 0.88 TSHR (0.37) ALDH1A1TSHRTHRBGAA
SCHEMBL6570936 0.86 MEN1 (0.32)
SCHEMBL9176884 0.85 ALDH1A1 (0.35) ALDH1A1TSHR
SCHEMBL5534960 0.84 CYP3A4 (0.33) TSHRTHRB
SCHEMBL5542838 0.84
SCHEMBL21634050 0.82 ALDH1A1 (0.39) ALDH1A1TSHRTHRB
SCHEMBL4182537 0.82 ALDH1A1 (0.36) ALDH1A1TSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176234-B2 Anticancer agents; side effect reduction CYTOVIA, INC. (US) 2007-02-13 US claimed
EP-1562598-A2 DERIVATIVES OF GAMBOGIC ACID AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS Cytovia, Inc. (US) 2005-08-17 EP claimed
US-20040082066-A1 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis CYTOVIA, INC. 2004-04-29 US claimed
WO-2004002428-A2 DERIVATIVES OF GAMBOGIC ACID AND INDUCE APOPTOSIS CYTOVIA, INC. (US) 2004-01-08 WO claimed
US-5631354-A ERYTHROMYCIN DERIVATIVES WITH IMPROVED ANTIBACTERIAL ACTIVITY TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-05-20 US claimed
US-5523399-A MACROLIDE ANTIBIOTICS HAVING A STRONG ANTIBACTERIAL ACTIVITY TAISHO PHARMACEUTICAL CO., LTD. (JP) 1996-06-04 US claimed
US-7176234-B2 Anticancer agents; side effect reduction CYTOVIA, INC. (US) 2007-02-13 US disclosed
EP-1562598-A2 DERIVATIVES OF GAMBOGIC ACID AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS Cytovia, Inc. (US) 2005-08-17 EP disclosed
US-20040082066-A1 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis CYTOVIA, INC. 2004-04-29 US disclosed
WO-2004002428-A2 DERIVATIVES OF GAMBOGIC ACID AND INDUCE APOPTOSIS CYTOVIA, INC. (US) 2004-01-08 WO disclosed
EP-0619320-B1 5-O-DESOSAMINYLERYTHRONOLIDE DERIVATIVE TAISHO PHARMACEUTICAL CO LTD (JP) 1997-05-21 EP disclosed
US-5631354-A ERYTHROMYCIN DERIVATIVES WITH IMPROVED ANTIBACTERIAL ACTIVITY TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-05-20 US disclosed
EP-0619319-B1 5-0-DESOSAMINYLERYTHRONOLIDE DERIVATIVE TAISHO PHARMACEUTICAL CO LTD (JP) 1997-03-05 EP disclosed
US-5523399-A MACROLIDE ANTIBIOTICS HAVING A STRONG ANTIBACTERIAL ACTIVITY TAISHO PHARMACEUTICAL CO., LTD. (JP) 1996-06-04 US disclosed
EP-0501167-B1 Liquid dye preparations BASF AG (DE) 1995-07-05 EP disclosed
EP-0619319-A1 5-0-DESOSAMINYLERYTHRONOLIDE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1994-10-12 EP disclosed
EP-0619320-A1 5-O-DESOSAMINYLERYTHRONOLIDE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1994-10-12 EP disclosed
US-5205838-A LIQUID DYE PREPARATIONS: BIS PHENYL-AZO-RESORCINOL IN SOLVENT FOR COLORED RIBBON OR BALL PEN INK BASF AKTIENGESELLSCHAFT (DE) 1993-04-27 US disclosed
EP-0501167-A1 Liquid dye preparations BASF Aktiengesellschaft (DE) 1992-09-02 EP disclosed